메뉴 건너뛰기




Volumn 107, Issue 7, 2006, Pages 1467-1474

The significance of neuroendocrine differentiation in adenocarcinoma of the esophagus and esophagogastric junction after preoperative chemoradiation

Author keywords

Adenocarcinoma; Chemoradiation; Esophagus; Neuroendocrine differentiation

Indexed keywords

CHROMOGRANIN A; CISPLATIN; FLUOROURACIL; PACLITAXEL; SYNAPTOPHYSIN;

EID: 33749619539     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.22179     Document Type: Article
Times cited : (31)

References (31)
  • 1
    • 0034908033 scopus 로고    scopus 로고
    • Esophageal adenocarcinoma: A review and perspectives on the mechanism of carcinogenesis and chemoprevention
    • Chen X, Yang CS. Esophageal adenocarcinoma: a review and perspectives on the mechanism of carcinogenesis and chemoprevention. Carcinogenesis. 2001;22:1119-1129.
    • (2001) Carcinogenesis , vol.22 , pp. 1119-1129
    • Chen, X.1    Yang, C.S.2
  • 2
    • 0036325365 scopus 로고    scopus 로고
    • Three-field lymph node dissection for squamous cell and adenocarcinoma of the esophagus
    • Altorki N, Kent M, Ferrara C, Port J. Three-field lymph node dissection for squamous cell and adenocarcinoma of the esophagus. Ann Surg. 2002;236:177-183.
    • (2002) Ann Surg , vol.236 , pp. 177-183
    • Altorki, N.1    Kent, M.2    Ferrara, C.3    Port, J.4
  • 3
    • 0033509879 scopus 로고    scopus 로고
    • Transhiatal esophagectomy: Clinical experience and refinements
    • discussion, 403
    • Orringer MB, Marshall B, Iannettoni MD. Transhiatal esophagectomy: clinical experience and refinements. Ann Surg. 1999;230:392-400; discussion, 403.
    • (1999) Ann Surg , vol.230 , pp. 392-400
    • Orringer, M.B.1    Marshall, B.2    Iannettoni, M.D.3
  • 4
    • 0033952968 scopus 로고    scopus 로고
    • Phase II evaluation of preoperative chemoradiation and postoperative adjuvant chemotherapy for squamous cell and adenocarcinoma of the esophagus
    • Heath EI, Burtness BA, Heitmiller RF, et al. Phase II evaluation of preoperative chemoradiation and postoperative adjuvant chemotherapy for squamous cell and adenocarcinoma of the esophagus. J Clin Oncol. 2000;18:868-876.
    • (2000) J Clin Oncol , vol.18 , pp. 868-876
    • Heath, E.I.1    Burtness, B.A.2    Heitmiller, R.F.3
  • 5
    • 0032585510 scopus 로고    scopus 로고
    • Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer
    • Kelsen DP, Ginsberg R, Pajak TF, et al. Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer. N Engl J Med. 1998;339:1979-1984.
    • (1998) N Engl J Med , vol.339 , pp. 1979-1984
    • Kelsen, D.P.1    Ginsberg, R.2    Pajak, T.F.3
  • 6
    • 0023108976 scopus 로고
    • The relationship of endocrine cells, dysplasia and carcinoembryonic antigen in Barren's mucosa to adenocarcinoma of the oesophagus
    • Griffin M, Sweeney EC. The relationship of endocrine cells, dysplasia and carcinoembryonic antigen in Barren's mucosa to adenocarcinoma of the oesophagus. Histopathology. 1987; 11:53-62.
    • (1987) Histopathology , vol.11 , pp. 53-62
    • Griffin, M.1    Sweeney, E.C.2
  • 7
    • 0034109005 scopus 로고    scopus 로고
    • Prevalence and prognostic significance of neuroendocrine cells in esophageal adenocarcinoma
    • Hamilton K, Chiappori A, Olson S, Sawyers J, Johnson D, Washington K. Prevalence and prognostic significance of neuroendocrine cells in esophageal adenocarcinoma. Mod Pathol. 2000;13:475-481.
    • (2000) Mod Pathol , vol.13 , pp. 475-481
    • Hamilton, K.1    Chiappori, A.2    Olson, S.3    Sawyers, J.4    Johnson, D.5    Washington, K.6
  • 8
    • 0036300880 scopus 로고    scopus 로고
    • Increased endocrine cells in treated rectal adenocarcinomas: A possible reflection of endocrine differentiation in tumor cells induced by chemotherapy and radiotherapy
    • Shia J, Tickoo SK, Guillem JG, et al. Increased endocrine cells in treated rectal adenocarcinomas: a possible reflection of endocrine differentiation in tumor cells induced by chemotherapy and radiotherapy. Am J Surg Pathol. 2002;26: 863-872.
    • (2002) Am J Surg Pathol , vol.26 , pp. 863-872
    • Shia, J.1    Tickoo, S.K.2    Guillem, J.G.3
  • 11
    • 20144362218 scopus 로고    scopus 로고
    • Posttherapy pathologic stage predicts survival in patients with esophageal carcinoma receiving preoperative chemoradiation
    • Chirieac LR, Swisher SG, Ajani JA, et al. Posttherapy pathologic stage predicts survival in patients with esophageal carcinoma receiving preoperative chemoradiation. Cancer. 2005; 103:1347-1355.
    • (2005) Cancer , vol.103 , pp. 1347-1355
    • Chirieac, L.R.1    Swisher, S.G.2    Ajani, J.A.3
  • 12
    • 0028305674 scopus 로고
    • Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma: Clinicopathologic correlations
    • Mandard AM, Dalibard F, Mandard JC, et al. Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma: clinicopathologic correlations. Cancer. 1994;73:2680-2686.
    • (1994) Cancer , vol.73 , pp. 2680-2686
    • Mandard, A.M.1    Dalibard, F.2    Mandard, J.C.3
  • 13
    • 0034544538 scopus 로고    scopus 로고
    • Neuroendocrine-like differentiation in patients with pancreatic carcinoma
    • Tezel E, Nagasaka T, Nomoto S, Sugimoto H, Nakao A. Neuroendocrine-like differentiation in patients with pancreatic carcinoma. Cancer. 2000;89:2230-2236.
    • (2000) Cancer , vol.89 , pp. 2230-2236
    • Tezel, E.1    Nagasaka, T.2    Nomoto, S.3    Sugimoto, H.4    Nakao, A.5
  • 14
    • 0344457271 scopus 로고    scopus 로고
    • Neuroendocrine differentiation in prostatic carcinoma
    • Abrahamsson PA. Neuroendocrine differentiation in prostatic carcinoma. Prostate. 1999;39:135-148.
    • (1999) Prostate , vol.39 , pp. 135-148
    • Abrahamsson, P.A.1
  • 15
    • 0345493852 scopus 로고    scopus 로고
    • Neuroendocrine differentiation in prostatic carcinomas: Histogenesis, biology, clinical relevance, and future therapeutical perspectives
    • Helpap B, Kollermann J, Oehler U. Neuroendocrine differentiation in prostatic carcinomas: histogenesis, biology, clinical relevance, and future therapeutical perspectives. Urol Int. 1999;62:133-138.
    • (1999) Urol Int , vol.62 , pp. 133-138
    • Helpap, B.1    Kollermann, J.2    Oehler, U.3
  • 16
    • 18344386395 scopus 로고    scopus 로고
    • Neuroendocrine differentiation and prognosis in breast adenocarcinoma
    • Miremadi A, Pinder SE, Lee AH, et al. Neuroendocrine differentiation and prognosis in breast adenocarcinoma. Histopathology. 2002;40:215-222.
    • (2002) Histopathology , vol.40 , pp. 215-222
    • Miremadi, A.1    Pinder, S.E.2    Lee, A.H.3
  • 17
    • 0028242569 scopus 로고
    • Mucinous carcinoma of the breast. A clinicopathologic, histochemical, and immunocytochemical study with special reference to neuroendocrine differentiation
    • Scopsi L, Andreola S, Pilotti S, et al. Mucinous carcinoma of the breast. A clinicopathologic, histochemical, and immunocytochemical study with special reference to neuroendocrine differentiation. Am J Surg Pathol. 1994;18:702-711.
    • (1994) Am J Surg Pathol , vol.18 , pp. 702-711
    • Scopsi, L.1    Andreola, S.2    Pilotti, S.3
  • 18
    • 0029115435 scopus 로고
    • Chromogranin gene expressions in colorectal adenocarcinomas
    • Pagani A, Papotti M, Abbona GC, Bussolati G. Chromogranin gene expressions in colorectal adenocarcinomas. Mod Pathol. 1995;8:626-632.
    • (1995) Mod Pathol , vol.8 , pp. 626-632
    • Pagani, A.1    Papotti, M.2    Abbona, G.C.3    Bussolati, G.4
  • 19
    • 0029850660 scopus 로고    scopus 로고
    • Chromogranin-A expression in neoplastic neuroendocrine cells and prognosis in colorectal cancer
    • Secco GB, Campora E, Fardelli R, et al. Chromogranin-A expression in neoplastic neuroendocrine cells and prognosis in colorectal cancer. Tumori. 1996;82:390-393.
    • (1996) Tumori , vol.82 , pp. 390-393
    • Secco, G.B.1    Campora, E.2    Fardelli, R.3
  • 20
    • 0031763593 scopus 로고    scopus 로고
    • The frequency and clinical significance of neuroendocrine cells within Stage III adenocarcinomas of the colon
    • Foley EF, Gaffey MJ, Frierson HF Jr. The frequency and clinical significance of neuroendocrine cells within Stage III adenocarcinomas of the colon. Arch Pathol Lab Med. 1998;122: 912-914.
    • (1998) Arch Pathol Lab Med , vol.122 , pp. 912-914
    • Foley, E.F.1    Gaffey, M.J.2    Frierson Jr., H.F.3
  • 21
    • 0035046711 scopus 로고    scopus 로고
    • Neuroendocrine differentiation is a relevant prognostic factor in Stage III-IV colorectal cancer
    • Grabowski P, Schindler I, Anagnostopoulos I, et al. Neuroendocrine differentiation is a relevant prognostic factor in Stage III-IV colorectal cancer. Eur J Gastroenterol Hepatol. 2001;13: 405-411.
    • (2001) Eur J Gastroenterol Hepatol , vol.13 , pp. 405-411
    • Grabowski, P.1    Schindler, I.2    Anagnostopoulos, I.3
  • 22
    • 0026508532 scopus 로고
    • Endocrine cells and prognosis in patients with colorectal carcinoma
    • Hamada Y, Oishi A, Shoji T, et al. Endocrine cells and prognosis in patients with colorectal carcinoma. Cancer. 1992;69: 2641-2646.
    • (1992) Cancer , vol.69 , pp. 2641-2646
    • Hamada, Y.1    Oishi, A.2    Shoji, T.3
  • 23
    • 0021366299 scopus 로고
    • The prevalence and prognostic significance of argyrophil cells in colorectal carcinomas
    • Smith DM Jr., Haggitt RC. The prevalence and prognostic significance of argyrophil cells in colorectal carcinomas. Am J Surg Pathol. 1984;8:123-128.
    • (1984) Am J Surg Pathol , vol.8 , pp. 123-128
    • Smith Jr., D.M.1    Haggitt, R.C.2
  • 25
    • 0027218879 scopus 로고
    • Endocrine cells in colorectal adenocarcinomas: Incidence, hormone profile and prognostic relevance
    • de Bruine AP, Wiggers T, Beek C, et al. Endocrine cells in colorectal adenocarcinomas: incidence, hormone profile and prognostic relevance. Int J Cancer. 1993;54:765-771.
    • (1993) Int J Cancer , vol.54 , pp. 765-771
    • De Bruine, A.P.1    Wiggers, T.2    Beek, C.3
  • 27
    • 0029093318 scopus 로고
    • The prevalence and clinical significance of chromogranin a and secretogranin II immunoreactivity in colorectal adenocarcinomas
    • Ferrero S, Buffa R, Pruneri G, et al. The prevalence and clinical significance of chromogranin A and secretogranin II immunoreactivity in colorectal adenocarcinomas. Virchows Arch. 1995;426:587-592.
    • (1995) Virchows Arch , vol.426 , pp. 587-592
    • Ferrero, S.1    Buffa, R.2    Pruneri, G.3
  • 28
    • 0028415657 scopus 로고
    • Prevalence and prognostic significance of endocrine cells in colorectal adenocarcinomas
    • Lapertosa G, Baracchini P, Delucchi F. Prevalence and prognostic significance of endocrine cells in colorectal adenocarcinomas. Pathologica. 1994;86:170-173.
    • (1994) Pathologica , vol.86 , pp. 170-173
    • Lapertosa, G.1    Baracchini, P.2    Delucchi, F.3
  • 29
    • 0033962683 scopus 로고    scopus 로고
    • Regressive changes and neuroendocrine differentiation in prostate cancer after neoadjuvant hormonal treatment
    • Ahlgren G, Pedersen K, Lundberg S, Aus G, Hugosson J, Abrahamsson PA. Regressive changes and neuroendocrine differentiation in prostate cancer after neoadjuvant hormonal treatment. Prostate. 2000;42:274-279.
    • (2000) Prostate , vol.42 , pp. 274-279
    • Ahlgren, G.1    Pedersen, K.2    Lundberg, S.3    Aus, G.4    Hugosson, J.5    Abrahamsson, P.A.6
  • 30
    • 26844531799 scopus 로고    scopus 로고
    • Neuroendocrine cells in benign and malignant prostate tissue: Morphogenesis, proliferation, and androgen receptor status
    • Bonkhoff H. Neuroendocrine cells in benign and malignant prostate tissue: morphogenesis, proliferation, and androgen receptor status. Prostate. 1998;8(Suppl):18-22.
    • (1998) Prostate , vol.8 , Issue.SUPPL. , pp. 18-22
    • Bonkhoff, H.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.